Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction.
Adjusted earnings increased 29% to $2.11 per share from $1.64 per share a year earlier. Analysts were looking for a smaller bottom-line number.
Net income, on an unadjusted basis, came in at $360 million or $0.29 per share, compared to a loss of $1.17 billion or $0.92 per share in the prior-year period.
Read management/analysts’ comments on Gilead Sciences Q3 earnings
Revenues moved up 17% year-over-year to $6.58 billion in the September-quarter and exceeded the market’s prediction. The company’s stock closed Wednesday’s regular trading lower, hut gained during the after-hours session.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
KinderCare Learning Companies to offer 24 Mln shares for $23-27 in US IPO
In 2024, the IPO market shifted to recovery mode, with a significant increase in activity compared to last year when it witnessed a slowdown. Encouraged by the booming stock market
Constellation Brands’ (STZ) beer business remains resilient in a tough environment
Shares of Constellation Brands, Inc. (NYSE: STZ) gained 1% on Friday. The stock has dropped 4% over the past three months. The beverages giant delivered better-than-expected earnings results for the
What to look for when Charles Schwab (SCHW) reports Q3 2024 results
Financial services company The Charles Schwab Corporation (NYSE: SCHW) is preparing to report third-quarter results on October 14, with experts predicting a mixed outcome. As part of its long-term succession
